corporate_fare

Ascendis Pharma Endocrinology Division A/S

Address
Tuborg Boulevard 12

Sponsor Overview

assignment
1
sponsored trial
science
2
molecules
location_city
30
research centres
public
5
countries
person_search
29
investigators

Specializations

Paediatric Endocrinology

Clinical research focused on growth disorders in children and adolescents, with attention to conditions affecting stature, growth pattern, and developmental height outcomes.

  • Idiopathic short stature
  • Short stature homeobox-containing gene deficiency
  • Small for gestational age
  • Turner syndrome

Trial activity centres on therapeutic approaches used in growth hormone-related care for paediatric patients with short stature and growth failure.

Growth Hormone Therapies

Research interest includes medical treatments for growth hormone sufficient disorders and other causes of impaired linear growth in young patients.

  • Somatropin
  • Lonapegsomatropin
  • Weekly growth hormone treatment
  • Height velocity

The sponsor’s clinical focus includes therapies relevant to pediatric height management and endocrine conditions associated with reduced growth.

Genetic and Syndromic Growth Disorders

Studies extend to inherited and syndromic conditions where genetic factors contribute to short stature and altered physical development.

  • SHOX deficiency
  • Turner syndrome
  • Hereditary short stature

This area reflects interest in therapies used for children with chromosomal or gene-related growth impairment.

International Paediatric Trial Network

Clinical activity spans multiple countries and research sites, supporting studies in children’s endocrinology across diverse clinical settings.

  • Collaborating research sites
  • Multinational recruitment
  • Paediatric patient access

The sponsor’s research footprint includes centres involved in endocrine treatment evaluation for growth-related conditions.

Sponsored Trials

Trial Name Country Status
Efficacy and Safety of Lonapegsomatropin Versus Somatropin in Children and Adolescents with Growth Failure or Short Stature Due to GH-Sufficient DisordersFrance FranceGermany GermanyItaly ItalyRomania RomaniaSpain SpainRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 2 total (0% not shared with other sponsors)

This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 30 sites collaborated multiple times

This sponsor has worked with 30 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Musculoskeletal Diseases1 trial
    238 other sponsors

Partnered Research Centres

30 centres
location_city
assignment103
A.O.U. Policlinico G. Martino Di Messina
Address
Via Consolare Valeria N 1, 98124 Messina
Learn morearrow_forward
location_city
assignment88
Assistance Publique Hopitaux De Paris
Address
26 Avenue Du Docteur Arnold Netter, 75012 Paris
Learn morearrow_forward
location_city
assignment523
Azienda Ospedaliera Universitaria Citta' Della Salute E Della Scienza Di Torino
Address
Via Cherasco 15, 10126 Turin
Learn morearrow_forward
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment133
Azienda Ospedaliera Universitaria Meyer IRCCS
Address
Viale Gaetano Pieraccini 24, 50139 Florence
Learn morearrow_forward
location_city
assignment283
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
Address
Piazza Luigi Miraglia 2, 80138 Naples
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Ascendis Pharma Endocrinology Division A/S.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.